Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019

Cynthia M. Magro, J. Justin Mulvey, Jeffrey Laurence, Surya Seshan, A. Neil Crowson, Andrew J. Dannenberg, Steven Salvatore, Joanna Harp, Gerard J. Nuovo

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

The purpose of this study was to examine the deltoid skin biopsy in twenty-three patients with coronavirus disease 2019 (COVID-19), most severely ill, for vascular complement deposition and correlate this with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA and protein localization and ACE2 expression. Deltoid skin microvascular complement screening has been applied to patients with various systemic complement-mediated microvascular syndromes, best exemplified by atypical hemolytic uremic syndrome. In 21 of 23 cases, substantial microvascular deposition of complement components was identified. The two patients without significant complement deposition included one patient with moderate disease and a severely ill patient who although on a ventilator for a day was discharged after 3 days. The dominant microvascular complement immunoreactant identified was the terminal membranolytic attack complex C5b-9. Microvascular complement deposition strongly colocalized in situ with the SARS-CoV-2 viral proteins including spike glycoproteins in the endothelial cells as well as the viral receptor ACE2 in lesional and nonlesional skin; viral RNA was not evident. Microvascular SARS-CoV-2 viral protein, complement, and ACE2 expression was most conspicuous in the subcutaneous fat. Although the samples from severely ill patients with COVID-19 were from grossly normal skin, light microscopically focal microvascular abnormalities were evident that included endothelial cell denudement, basement membrane zone reduplication, and small thrombi. It is concluded that complement activation is common in grossly normal skin, especially in the subcutaneous fat which may provide a link between severe disease and obesity, in people with severe COVID-19, and the strong colocalization with the ACE2 receptor and viral capsid proteins without viral RNA suggests that circulating viral proteins (ie, pseudovirions) may dock onto the endothelial of these microvessels and induce complement activation.

Original languageEnglish (US)
Pages (from-to)106-116
Number of pages11
JournalHuman Pathology
Volume106
DOIs
StatePublished - Dec 2020

Keywords

  • ACE2
  • COVID-19
  • Complement
  • Deltoid biopsy
  • SARS-CoV-2
  • Skin
  • Microvessels/metabolism
  • Peptidyl-Dipeptidase A/genetics
  • Humans
  • Middle Aged
  • RNA, Viral/genetics
  • SARS-CoV-2/pathogenicity
  • Male
  • Angiotensin-Converting Enzyme 2/metabolism
  • Complement Activation/immunology
  • Endothelial Cells/metabolism
  • COVID-19/metabolism
  • Adult
  • Female
  • Aged

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019'. Together they form a unique fingerprint.

Cite this